In addition to the well-described role of astrocytic AQP4, we believe that choroid plexus AQP4 expression may change with physiological and pathological conditions, with the following effects on glymphatic clearance activity that may contribute to the development of neurodegenerative diseases, including AD. Here, AQP4 is linked to neurodegenerative disease.